Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.

Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amou...

Full description

Bibliographic Details
Main Authors: Gabriel N Defang, Nicholas J Martin, Timothy H Burgess, Eugene V Millar, LeNae A Pecenka, Janine R Danko, John C Arnold, Tadeusz J Kochel, Thomas C Luke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3527466?pdf=render
id doaj-cb7f4b129cfa4a01a587734959370177
record_format Article
spelling doaj-cb7f4b129cfa4a01a5877349593701772020-11-25T02:50:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e4822910.1371/journal.pone.0048229Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.Gabriel N DefangNicholas J MartinTimothy H BurgessEugene V MillarLeNae A PecenkaJanine R DankoJohn C ArnoldTadeusz J KochelThomas C LukeInfluenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amount of blood collected during studies and the availability of plasma in archived sample collections warrant the evaluation of plasma for HAI titer. Therefore, the relationship between serum and plasma HAI titer values is of great interest. Here, we compare HAI titers determined on temporally matched serum and plasma (citrated and heparinized) using influenza A and B viruses. Bland-Altman plots, McNemar's test, and geometric coefficient of variation were used respectively for evaluating agreement, correlation and variability in the serum-plasma titer results. We observed a high degree of agreement (80.5%-98.8%) and correlation (r = 0.796-0.964) in the serum and matched plasma titer values although plasma titers were generally lower than corresponding serum titers. Calculated seropositive (HAI ≥40) rates were higher using serum titers than with plasma titers, but seroconversion rates were unaffected by sample type. Stronger agreement and decreased variability in titers were seen between serum and citrated plasma than between serum and heparinized plasma. Overall, these data suggest that serum or plasma can be used in serodiagnostic HAI assays, but seropositive rates may be underestimated using plasma HAI titers. The type of anticoagulant present in plasma may affect HAI titer values and warrants further investigation.http://europepmc.org/articles/PMC3527466?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Gabriel N Defang
Nicholas J Martin
Timothy H Burgess
Eugene V Millar
LeNae A Pecenka
Janine R Danko
John C Arnold
Tadeusz J Kochel
Thomas C Luke
spellingShingle Gabriel N Defang
Nicholas J Martin
Timothy H Burgess
Eugene V Millar
LeNae A Pecenka
Janine R Danko
John C Arnold
Tadeusz J Kochel
Thomas C Luke
Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
PLoS ONE
author_facet Gabriel N Defang
Nicholas J Martin
Timothy H Burgess
Eugene V Millar
LeNae A Pecenka
Janine R Danko
John C Arnold
Tadeusz J Kochel
Thomas C Luke
author_sort Gabriel N Defang
title Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
title_short Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
title_full Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
title_fullStr Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
title_full_unstemmed Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
title_sort comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amount of blood collected during studies and the availability of plasma in archived sample collections warrant the evaluation of plasma for HAI titer. Therefore, the relationship between serum and plasma HAI titer values is of great interest. Here, we compare HAI titers determined on temporally matched serum and plasma (citrated and heparinized) using influenza A and B viruses. Bland-Altman plots, McNemar's test, and geometric coefficient of variation were used respectively for evaluating agreement, correlation and variability in the serum-plasma titer results. We observed a high degree of agreement (80.5%-98.8%) and correlation (r = 0.796-0.964) in the serum and matched plasma titer values although plasma titers were generally lower than corresponding serum titers. Calculated seropositive (HAI ≥40) rates were higher using serum titers than with plasma titers, but seroconversion rates were unaffected by sample type. Stronger agreement and decreased variability in titers were seen between serum and citrated plasma than between serum and heparinized plasma. Overall, these data suggest that serum or plasma can be used in serodiagnostic HAI assays, but seropositive rates may be underestimated using plasma HAI titers. The type of anticoagulant present in plasma may affect HAI titer values and warrants further investigation.
url http://europepmc.org/articles/PMC3527466?pdf=render
work_keys_str_mv AT gabrielndefang comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT nicholasjmartin comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT timothyhburgess comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT eugenevmillar comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT lenaeapecenka comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT janinerdanko comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT johncarnold comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT tadeuszjkochel comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
AT thomascluke comparativeanalysisofhemagglutinationinhibitiontitersgeneratedusingtemporallymatchedserumandplasmasamples
_version_ 1724740242362073088